+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biomarkers Market (2021-2026) by Type, Disease Indication, Application, Components, End User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 203 Pages
  • May 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5397300
The Global Biomarkers Market is estimated to be USD 40.27 Bn in 2021 and is expected to reach USD 74.03 Bn by 2026, growing at a CAGR of 12. 95%.

Market Dynamics

The government projects and programs that support the health care sector have prompted the global biomarkers market. The increasing prevalence of diseases such as cancer, cardiovascular diseases, and neurological diseases and the growing demand for biomarkers treatment are majorly increasing the market growth. In addition, the vital role of Biomarkers in disease risk management, drug discovery & development, personalized medicine, disease diagnosis, etc., is further propelling the market growth. However, the need for high capital investment, unfavorable regulatory and settlement policies, and high R & D cost of R&D is anticipated to hinder the market growth.

Market Segmentation

The Global Biomarkers Market is segmented further based on Type, Disease Indication, Application, Components, End User, and Geography.

By Type, the market is classified into safety biomarkers, efficacy biomarkers, validation biomarkers. Amongst all, the safety biomarkers segment is estimated to hold the highest market share during the forecast period.

By Diseases Indication, the market is classified as cancer, cardiovascular disorders, neurological disorders, immunological disorders, and others. Amongst all, the cancer segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified as diagnostics, drug discovery and development, personalized medicine, disease risk assessment, and others. Amongst all, the personalized medicine segment is estimated to hold the highest market share during the forecast period.

By Components, the market is classified as consumables, services, and software. Amongst all, the consumables segment is estimated to hold the highest market share during the forecast period.

By End User, the market is classified as pharmaceutical companies, CRO's, diagnostic centers, academic research institutes, and others. Amongst all, the pharmaceutical companies segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Amgen launches Biomarker Assist, a program to help more patients with metastatic non-small cell lung cancer gain access to biomarker testing - 19th April 2021
2. Biocartis announces new collaboration with AstraZeneca to expand the availability of Idylla™ EGFR biomarker testing among patients with lung cancer at selected hospital sites in Biocartis’ European and global distributor markets - 4th May 2021
3. Bio-Rad introduces reliance select cDNA synthesis kit, a reverse transcription solution that efficiently converts RNA to DNA. A more sensitive reverse transcription will help for the discovery of new biomarkers - 11th March 2020

Company Profiles

Some of the companies covered in this report are AstraZeneca, Qiagen N.V, Thermo Fisher Scientific Inc, Hoffmann-La Roche Ltd, PerkinElmer Inc, Merck Group, Bio-Rad Laboratories, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Biomarkers Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s positioning tool.

Report Highlights:
  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Biomarkers Market

What is the estimated value of the Global Biomarkers Market?

The Global Biomarkers Market was estimated to be valued at $40270 Million in 2021.

What is the growth rate of the Global Biomarkers Market?

The growth rate of the Global Biomarkers Market is 12.9%, with an estimated value of $74030 Million by 2026.

What is the forecasted size of the Global Biomarkers Market?

The Global Biomarkers Market is estimated to be worth $74030 Million by 2026.

Who are the key companies in the Global Biomarkers Market?

Key companies in the Global Biomarkers Market include Sino Biological Inc., Abbott, Axon Medchem, AstraZeneca, Becton, Dickinson and Company, Bio, Rad Laboratories, Biosims Technologies SAS and Techne Corporation.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Growing Clinical Trials in Biopharmaceutical Sector
4.1.2 Rising Prevalence of Cancer
4.1.3 Personalized Medicine
4.2 Restraints
4.2.1 Sample Collection and Storage Challenges
4.2.2 High Investment Cost
4.3 Opportunities
4.3.1 Government Initiative Towards Development
4.3.2 Continiuous Product Innovation
4.4 Challenges
4.4.1 No Standard Regulatory Framework and Ethical Problems
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Biomarkers Market, By Type
6.1 Introduction
6.2 Safety Biomarkers
6.3 Efficacy Biomarkers
6.3.1 Predictive Biomarkers
6.3.2 Surrogate Biomarkers
6.3.3 Pharmacodynamic Biomarkers
6.3.4 Prognostic Biomarkers
6.4 Validation Biomarkers
7 Global Biomarkers Market, By Disease Indication
7.1 Introduction
7.2 Cancer
7.3 Cardiovascular Disorders
7.4 Neurological Disorders
7.5 Immunological Disorders
7.6 Others
8 Global Biomarkers Market, By Application
8.1 Introduction
8.2 Diagnostics
8.3 Drug Discovery and Development
8.4 Personalized Medicine
8.5 Disease Risk Assessment
8.6 Others
9 Global Biomarkers Market, By Components
9.1 Introduction
9.2 Consumables
9.3 Services
9.3.1 Sample Preparation
9.3.2 Assay Development
9.3.3 Biomarker Validation and Testing
9.3.4 Other Services
9.4 Software
10 Global Biomarkers Market, By End User
10.1 Introduction
10.2 Pharmaceutical Companies
10.3 CRO’s
10.4 Diagnostic Centers
10.5 Academic Research Institutes
10.6 Others
11 Global Biomarkers Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 South America
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Chile
11.3.4 Colombia
11.4 Europe
11.4.1 UK
11.4.2 France
11.4.3 Germany
11.4.4 Italy
11.4.5 Spain
11.4.6 Netherlands
11.4.7 Sweden
11.4.8 Russia
11.4.9 Rest of Europe
11.5 Asia-Pacific
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Indonesia
11.5.5 Malaysia
11.5.6 South Korea
11.5.7 Australia
11.5.8 Sri Lanka
11.5.9 Thailand
11.5.10 Rest of APAC
11.6 Middle-East and Africa
11.6.1 Qatar
11.6.2 Saudi Arabia
11.6.3 South Africa
11.6.4 United Arab Emirates
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Sino Biological Inc.
13.2 Abbott
13.3 Axon Medchem
13.4 AstraZeneca
13.5 Becton, Dickinson and Company
13.6 Bio-Rad Laboratories
13.7 Biosims Technologies SAS
13.8 Bio-Techne Corporation
13.9 BioVision Inc
13.11 Cisbio Bioassays
13.12 EKF Diagnostics Holdings PLC
13.13 Enzo Biochem, Inc
13.14 Epigenomics Inc.
13.15 F. Hoffmann-La Roche Ltd
13.16 GE Healthcare
13.17 Johnson & Johnson Private Limited
13.18 Merck Group
13.19 Meso Scale Diagnostics, Llc
13.20 Myriad RBM, Inc.
13.21 PerkinElmer Inc
13.22 QIAGEN GmbH
13.23 F. Hoffmann-La Roche AG
13.24 Siemens Healthineers AG
13.25 Signosis, Inc
13.26 Thermo Fisher Scientific, Inc.
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • Sino Biological Inc.
  • Abbott
  • Axon Medchem
  • AstraZeneca
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Biosims Technologies SAS
  • Bio-Techne Corporation
  • BioVision Inc
  • Cisbio Bioassays
  • EKF Diagnostics Holdings PLC
  • Enzo Biochem, Inc
  • Epigenomics Inc.
  • F. Hoffmann-La Roche Ltd
  • General Electric Company
  • Johnson & Johnson Private Limited
  • Merck Group
  • Meso Scale Diagnostics, Llc
  • Myriad RBM, Inc.
  • PerkinElmer Inc
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Signosis, Inc
  • Thermo Fisher Scientific, Inc.